aplastic anemia | Page 32 | Aplastic Anemia and MDS International Foundation

aplastic anemia

Pathophysiology and management of thrombocytopenia in bone marrow failure: possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes.

Author(s): 
Townsley DM, Desmond R, Dunbar CE, Young NS.
Primary Author: 
Townsley DM
Journal Title: 
Int J Hematol
Original Publication Date: 
May 2013

Bone Marrow Diseases: 

Reduced dose cyclophosphamide, fludarabine and antithymocyte globulin for sibling and unrelated transplant of children with severe and very severe aplastic anemia.

Author(s): 
Chung NG, Lee JW, Jang PS, Jeong DC, Cho B, Kim HK
Primary Author: 
Chung NG
Journal Title: 
Pediatr Transplant
Original Publication Date: 
Apr 2013

We evaluated the results of a novel conditioning regimen of reduced dose

Bone Marrow Diseases: 

Less could be better: The case for reducing the dose of cyclophosphamide for children undergoing allogeneic stem cell transplant for severe aplastic anemia.

Author(s): 
Hussein AA, Frangoul H
Primary Author: 
Hussein AA
Journal Title: 
Pediatr Transplant
Original Publication Date: 
Apr 2013

No abstract available.

Bone Marrow Diseases: 

Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia

Author(s): 
Takahashi Y, Muramatsu H, Sakata N, Hyakuna N, Hamamoto K, Kobayashi R, Ito E, Yagasaki H, Ohara A, Kikuchi A, Morimoto A, Yabe H, Kudo K, Watanabe K, Ohga S, Kojima S
Primary Author: 
Takahashi Y
Journal Title: 
Blood
Original Publication Date: 
Jan 2013

No abstract available

Bone Marrow Diseases: 

Excellent Outcome of Haploidentical Hematopoietic Stem Cell Transplantation in Children and Adolescents with Acquired Severe Aplastic Anemia

Author(s): 
Im HJ, Koh KN, Choi ES, Jang S, Kwon SW, Park CJ, Chi HS, Seo JJ
Primary Author: 
Im HJ
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
Feb 2013

We evaluated the outcome of children and adolescents with acquired severe

Bone Marrow Diseases: 

Engraftment of heavily transfused patients with severe aplastic anemia with a fludarabine-based regimen

Author(s): 
Wang SB, Li L, Pan XH, Hu DM, Peng LH, Liu L, Xie ZJ, Yin B, Sun XJ, Yu J, Liang Y
Primary Author: 
Wang SB
Journal Title: 
Clin Transplant
Original Publication Date: 
Feb 2013

We have developed a practical conditioning regimen without anti-thymocyte globulin (ATG), irradiation, or other myeloablative alkylating agent for low-income countries in which patients with severe

Bone Marrow Diseases: